Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
<p>Statistics from DESeq2</p>
Uloženo v:
Podobné jednotky
-
Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
Autor: Alyssa C. Flint (16676029)
Vydáno: (2025) -
Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Autor: Elizabeth R. Tucker (15053624)
Vydáno: (2025) -
Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Autor: Elizabeth R. Tucker (15053624)
Vydáno: (2025) -
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Autor: Elizabeth R. Tucker (15053624)
Vydáno: (2025) -
Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Autor: Elizabeth R. Tucker (15053624)
Vydáno: (2025)